FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market
This is a discussion on FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market within the FDA Recalls, Market Withdrawals and Safety Alerts forum, part of the Industry News and Updates category; Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-08-2009, 11:55 PM
|
|||
|
|||
FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market
Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of the product from the U.S. market. The company is taking this action because of a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML), a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system. By June 8, 2009, Raptiva will no longer be available in the United States.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) pat | industry_news | FDA Recalls, Market Withdrawals and Safety Alerts | 0 | 03-23-2009 01:31 PM |
| New International Consensus Statement on Bipolar Depression | industry_news | Other Clinical Pharmacy News | 0 | 09-05-2008 03:28 PM |
| AHA Issues Statement on Ambulatory BP Monitoring in Youths | industry_news | Other Clinical Pharmacy News | 0 | 08-07-2008 06:23 PM |
| Prednisone Eases Withdrawal Headache After Medication Overuse Reuters Health Informat | industry_news | Other Clinical Pharmacy News | 0 | 03-01-2008 11:43 AM |
| Bayer and FDA inform healthcare professionals of the market withdrawal of the current | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |